z-logo
open-access-imgOpen Access
Lack of Long-term Effects of In Utero Exposure to Zidovudine Among Uninfected Children Born to HIV-Infected Women
Author(s) -
Mary Culnane,
Mary Glenn Fowler,
Sophia S. Lee,
George McSherry,
Michael T. Brady,
Karen O’Donnell,
Lynne Mofenson,
Steven L. Gortmaker,
David E. Shapiro,
Gwendolyn B. Scott,
Eleanor Jiménez,
Ellen Moore,
Clemente Díaz,
Patricia M. Flynn,
Bethann E. Cunningham,
James M. Oleske
Publication year - 1999
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.281.2.151
Subject(s) - zidovudine , medicine , pediatrics , chemoprophylaxis , placebo , lamivudine , cohort , pregnancy , in utero , immunology , viral disease , human immunodeficiency virus (hiv) , fetus , pathology , virus , hepatitis b virus , alternative medicine , biology , genetics
With the success of zidovudine chemoprophylaxis for prevention of perinatal transmission of the human immunodeficiency virus (HIV), an increasing number of HIV-exposed but uninfected children will have in utero exposure to zidovudine and other antiretroviral drugs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom